You are here : Home / Quarterly Results / PIRAMAL ENTERPRISES LTD

PIRAMAL ENTERPRISES Quarterly Results Analysis Q2FY22 [Sep2021]

Q-o-Q REVENUES OPERATING PROFIT PROFIT AFTER TAX EPS Updated : 11-Nov-21 Details👇

PIRAMAL ENTERPRISES Quarterly Results

Consolidated Sep2021
UnAudited
Jun2021
Audited
Mar2021
Audited
Dec2020
UnAudited
Sep2020
UnAudited
Jun2020
Audited
Mar2020
Audited
Dec2019
UnAudited
Revenues ₹3,106 Cr ₹2,909 Cr ₹3,402 Cr ₹3,169 Cr ₹3,302 Cr ₹2,937 Cr ₹3,341 Cr ₹3,270 Cr
Expenses ₹1,551 Cr ₹1,359 Cr ₹1,624 Cr ₹1,278 Cr ₹1,302 Cr ₹1,142 Cr ₹3,439 Cr ₹1,151 Cr
Operating Income ₹1,554 Cr ₹1,550 Cr ₹1,778 Cr ₹1,891 Cr ₹2,000 Cr ₹1,795 Cr ₹-98 Cr ₹2,119 Cr
Other Income ₹128 Cr ₹103 Cr ₹164 Cr ₹96 Cr ₹38 Cr ₹65 Cr ₹240 Cr ₹141 Cr
Interest ₹963 Cr ₹985 Cr ₹936 Cr ₹1,012 Cr ₹1,156 Cr ₹1,105 Cr ₹1,295 Cr ₹1,360 Cr
Depreciation ₹153 Cr ₹149 Cr ₹145 Cr ₹142 Cr ₹139 Cr ₹135 Cr ₹143 Cr ₹128 Cr
Profit Before Tax ₹413 Cr ₹504 Cr ₹861 Cr ₹853 Cr ₹782 Cr ₹622 Cr ₹-1,296 Cr ₹772 Cr
Profit After Tax ₹310 Cr ₹368 Cr ₹-616 Cr ₹652 Cr ₹578 Cr ₹461 Cr ₹-2,556 Cr ₹545 Cr
EPS ₹17.56 ₹22.60 ₹-25.33 ₹34.57 ₹27.86 ₹21.97 ₹-75.46 ₹36.40

Check out Industry Peers

Peers & Returns1W1M1Y
PIRAMAL ENTERPRISES 4.5% -4.9% 81.4%
SUN PHARMACEUTICAL INDUSTRIES -1.1% -5.3% 36.4%
DIVIS LABORATORIES -5.6% -10.5% 28.2%
DR REDDYS LABORATORIES -2.4% -4.1% -6.2%
CIPLA -2.6% -1.7% 17.3%
GLAND PHARMA -3.1% -3.4% 62.5%
CADILA HEALTHCARE 0.4% -6.6% -0.4%
TORRENT PHARMACEUTICALS 5.5% 8.2% 14.4%
ALKEM LABORATORIES -0.6% -4.2% 22.7%

PIRAMAL ENTERPRISES Quarterly Revenues

Revenues
Q-o-Q

6.77 %

Y-o-Y

-5.95 %

Quarters Revenues % Change
Sep2021 ₹3,106 Cr
6.77
Jun2021 ₹2,909 Cr
-14.49
Mar2021 ₹3,402 Cr
7.35
Dec2020 ₹3,169 Cr
-4.04
Sep2020 ₹3,302 Cr
12.41
Jun2020 ₹2,937 Cr
-12.08
Mar2020 ₹3,341 Cr
2.17
Dec2019 ₹3,270 Cr -

PIRAMAL ENTERPRISES Quarterly Operating Profit

Operating Profit
Q-o-Q

0.28 %

Y-o-Y

-22.29 %

Quarters Operating Profit % Change
Sep2021 ₹1,554 Cr
0.28
Jun2021 ₹1,550 Cr
-12.83
Mar2021 ₹1,778 Cr
-5.98
Dec2020 ₹1,891 Cr
-5.45
Sep2020 ₹2,000 Cr
11.39
Jun2020 ₹1,795 Cr
Positive
Mar2020 ₹-98 Cr
Negative
Dec2019 ₹2,119 Cr -
Operating Margins
Q-o-Q

-6.08 %

Y-o-Y

-17.38 %

Quarters Operating Margin% % Change
Sep2021 50.04%
-6.08
Jun2021 53.28%
1.93
Mar2021 52.27%
-12.42
Dec2020 59.68%
-1.47
Sep2020 60.57%
-0.92
Jun2020 61.13%
Positive
Mar2020 -2.92%
Negative
Dec2019 64.79% -

PIRAMAL ENTERPRISES Quarterly Profit After Tax

Profit After Tax(PAT)
Q-o-Q

-15.87 %

Y-o-Y

-46.38 %

Quarters Profit After Tax % Change
Sep2021 ₹310 Cr
-15.87
Jun2021 ₹368 Cr
Positive
Mar2021 ₹-616 Cr
Negative
Dec2020 ₹652 Cr
12.79
Sep2020 ₹578 Cr
25.50
Jun2020 ₹461 Cr
Positive
Mar2020 ₹-2,556 Cr
Negative
Dec2019 ₹545 Cr -
PAT Margins
Q-o-Q

-21.23 %

Y-o-Y

-43.00 %

Quarters PAT Margin(%) % Change
Sep2021 9.98 %
-21.23
Jun2021 12.67 %
Positive
Mar2021 -18.12 %
Negative
Dec2020 20.58 %
17.53
Sep2020 17.51 %
11.67
Jun2020 15.68 %
Positive
Mar2020 -76.49 %
Negative
Dec2019 16.67 % -

PIRAMAL ENTERPRISES Quarterly Earnings Per Share (EPS)

EPS
Q-o-Q

-22.30 %

Y-o-Y

-36.97 %

Quarters EPS % Change
Sep2021 ₹17.56
-22.30
Jun2021 ₹22.6
Positive
Mar2021 ₹-25.33
Negative
Dec2020 ₹34.57
24.08
Sep2020 ₹27.86
26.81
Jun2020 ₹21.97
Positive
Mar2020 ₹-75.46
Negative
Dec2019 ₹36.4 -
STOCK RESEARCH & ANALYSIS Smart-Investing
LEARN VIA VIDEO COURSE Stock Market Investing Simplified- The best Video Course by Smart-Investing.in

PIRAMAL ENTERPRISES related INDICES

BSE Indices1W1M1Y
S&P BSE FINANCE 1.7% -5.1% 25.1%
S&P BSE SENSEX NEXT 50 1% -2.4% 39.4%
S&P BSE ALLCAP 0.7% -2.8% 38.3%
S&P BSE 500 0.6% -3% 37.1%
S&P BSE LARGE MIDCAP 0.6% -3.1% 34.2%
S&P BSE 200 0.6% -3.1% 34.8%
S&P BSE 250 LARGEMIDCAP 0.5% -3.1% 35.5%
S&P BSE CARBONEX 0.5% -3.1% 32.2%
S&P BSE 100 0.5% -3.1% 32.6%
S&P BSE 100 ESG INDEX 0.4% -3.3% 33.5%
S&P BSE LARGECAP 0.4% -3.1% 32.1%
S&P BSE 100 LARGECAP TMC 0.4% -3.1% 32.5%
NSE Indices1W1M1Y
NIFTY FINANCE 1.7% -4.9% 25.3%
NIFTY FINANCIAL SERVICES 25_50 1.4% -5.2% NA
NIFTY500 MULTICAP 50:25:25 1% -2.4% NA
NIFTY LARGE MIDCAP 250 0.8% -2.8% 41.7%
NIFTY 100 EQUAL WEIGHT 0.8% -3.7% 39.2%
NIFTY 500 0.7% -2.9% 36.9%
NIFTY NEXT 50 0.6% -2.2% 37.2%
NIFTY 200 0.6% -3.1% 34.4%
NIFTY 100 0.4% -3.1% 32.1%

You may also like the below Video Courses

Check out Intrinsic Value of Industry Peers
Intrinsic Value of SUN PHARMACEUTICAL INDUSTRIES LTD
Intrinsic Value of DIVIS LABORATORIES LTD
Intrinsic Value of DR REDDYS LABORATORIES LTD
Intrinsic Value of CIPLA LTD
Intrinsic Value of GLAND PHARMA LTD
Intrinsic Value of PIRAMAL ENTERPRISES LTD
Intrinsic Value of CADILA HEALTHCARE LTD
Intrinsic Value of TORRENT PHARMACEUTICALS LTD
Intrinsic Value of ALKEM LABORATORIES LTD
Intrinsic Value of LUPIN LTD
Intrinsic Value of AUROBINDO PHARMA LTD
Intrinsic Value of BIOCON LTD
Intrinsic Value of ABBOTT INDIA LTD
Intrinsic Value of LAURUS LABS LTD
Intrinsic Value of IPCA LABORATORIES LTD
Check out Annual Financials of Industry Peers
Share Price & Financials of SUN PHARMACEUTICAL INDUSTRIES LTD | BOM: 524715 | NSE: SUNPHARMA
Share Price & Financials of DIVIS LABORATORIES LTD | BOM: 532488 | NSE: DIVISLAB
Share Price & Financials of DR REDDYS LABORATORIES LTD | BOM: 500124 | NSE: DRREDDY
Share Price & Financials of CIPLA LTD | BOM: 500087 | NSE: CIPLA
Share Price & Financials of GLAND PHARMA LTD | BOM: 543245 | NSE: GLAND
Share Price & Financials of PIRAMAL ENTERPRISES LTD | BOM: 500302 | NSE: PEL
Share Price & Financials of CADILA HEALTHCARE LTD | BOM: 532321 | NSE: CADILAHC
Share Price & Financials of TORRENT PHARMACEUTICALS LTD | BOM: 500420 | NSE: TORNTPHARM
Share Price & Financials of ALKEM LABORATORIES LTD | BOM: 539523 | NSE: ALKEM
Share Price & Financials of LUPIN LTD | BOM: 500257 | NSE: LUPIN
Share Price & Financials of AUROBINDO PHARMA LTD | BOM: 524804 | NSE: AUROPHARMA
Share Price & Financials of BIOCON LTD | BOM: 532523 | NSE: BIOCON
Share Price & Financials of ABBOTT INDIA LTD | BOM: 500488 | NSE: ABBOTINDIA
Share Price & Financials of LAURUS LABS LTD | BOM: 540222 | NSE: LAURUSLABS
Share Price & Financials of IPCA LABORATORIES LTD | BOM: 524494 | NSE: IPCALAB

Compare Analytics
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs DR REDDYS LABORATORIES LTD
CIPLA LTD vs GLAND PHARMA LTD vs PIRAMAL ENTERPRISES LTD
CADILA HEALTHCARE LTD vs TORRENT PHARMACEUTICALS LTD vs ALKEM LABORATORIES LTD
LUPIN LTD vs AUROBINDO PHARMA LTD vs BIOCON LTD
ABBOTT INDIA LTD vs LAURUS LABS LTD vs IPCA LABORATORIES LTD
Browse Market Cap of Industry Peers
Market Cap of SUN PHARMACEUTICAL INDUSTRIES LTD
Market Cap of DIVIS LABORATORIES LTD
Market Cap of DR REDDYS LABORATORIES LTD
Market Cap of CIPLA LTD
Market Cap of GLAND PHARMA LTD
Market Cap of PIRAMAL ENTERPRISES LTD
Market Cap of CADILA HEALTHCARE LTD
Market Cap of TORRENT PHARMACEUTICALS LTD
Market Cap of ALKEM LABORATORIES LTD
Market Cap of LUPIN LTD
Market Cap of AUROBINDO PHARMA LTD
Market Cap of BIOCON LTD
Market Cap of ABBOTT INDIA LTD
Market Cap of LAURUS LABS LTD
Market Cap of IPCA LABORATORIES LTD

Disclosure

SEBI Research Analyst
The Founder of this website, Mr. Rohit Katiyar is registered with SEBI as a Research Analyst [INH000007377].


All Stocks : A - Z

ALL   A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z